State Street Corporation (NYSE: STT) reports 6.3% beneficial stake in Ocugen
Rhea-AI Filing Summary
State Street Corporation reported a significant ownership stake in Ocugen Inc. common stock. State Street beneficially owns 21,469,307 shares of Ocugen common stock, representing 6.3% of the class as of June 30, 2026.
State Street reports no sole voting or dispositive power over these shares. It has shared voting power over 21,055,589 shares and shared dispositive power over 21,469,307 shares, largely through its asset management subsidiaries SSGA Funds Management, Inc., State Street Global Advisors Europe Limited, and State Street Global Advisors Trust Company.
Positive
- None.
Negative
- None.
Key Figures
Beneficial ownership: 21,469,307 shares
Percent of class: 6.3%
Shared voting power: 21,055,589 shares
+3 more
6 metrics
Beneficial ownership
21,469,307 shares
Ocugen common stock beneficially owned by State Street Corporation
Percent of class
6.3%
Portion of Ocugen common stock class held by State Street Corporation
Shared voting power
21,055,589 shares
Shares of Ocugen over which State Street has shared voting power
Shared dispositive power
21,469,307 shares
Shares of Ocugen over which State Street has shared dispositive power
CUSIP
67577C105
CUSIP number for Ocugen Inc. common stock
As-of date
06/30/2026
Date for reported ownership information
Key Terms
beneficially owned, shared voting power, shared dispositive power, Investment Company Act of 1940, +1 more
5 terms
beneficially owned financial
"Amount beneficially owned: 21469307.00"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Investment Company Act of 1940 regulatory
"investment company registered under the Investment Company Act of 1940"
A U.S. federal law that sets the rulebook for pooled investment vehicles such as mutual funds, exchange-traded funds and similar money managers, requiring them to register with regulators, disclose holdings and fees, limit conflicts of interest, and follow governance standards. It matters to investors because these protections and transparency rules act like a referee and scoreboard, helping people compare funds, trust that managers follow fair practices, and spot hidden costs or risks.
Schedule 13G regulatory
"Ownership of more than 5 Percent on Behalf of Another Person."
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What percentage of Ocugen Inc (OCGN) does State Street Corporation own?
State Street Corporation beneficially owns 6.3% of Ocugen Inc.'s common stock, representing 21,469,307 shares as of June 30, 2026, according to the Schedule 13G ownership report.
Does State Street have dispositive power over its Ocugen (OCGN) holdings?
Yes. State Street reports shared dispositive power over 21,469,307 Ocugen shares and no sole dispositive power, meaning decisions to sell are shared, typically through its investment management entities.
Which State Street subsidiaries are tied to the Ocugen (OCGN) holdings?
The report links the Ocugen holdings to SSGA Funds Management, Inc., State Street Global Advisors Europe Limited, and State Street Global Advisors Trust Company, all classified as investment advisers (IA).
Is any other person disclosed as having rights to Ocugen (OCGN) dividends or sale proceeds?
The filing states "NOT APPLICABLE" for others having the right to receive dividends or sale proceeds over 5% of the class, indicating no such specific party is identified.